271 related articles for article (PubMed ID: 12193749)
1. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen.
Ohata K; Espinoza JL; Lu X; Kondo Y; Nakao S
Biol Blood Marrow Transplant; 2011 Feb; 17(2):205-13. PubMed ID: 20736080
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
Dayton JS; Turka LA; Thompson CB; Mitchell BS
Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
[TBL] [Abstract][Full Text] [Related]
5. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
6. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes.
Laliberté J; Yee A; Xiong Y; Mitchell BS
Blood; 1998 Apr; 91(8):2896-904. PubMed ID: 9531600
[TBL] [Abstract][Full Text] [Related]
7. Sanglifehrin A, a novel cyclophilin-binding immunosuppressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the cell cycle.
Zhang LH; Liu JO
J Immunol; 2001 May; 166(9):5611-8. PubMed ID: 11313401
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion.
Eugui EM; Almquist SJ; Muller CD; Allison AC
Scand J Immunol; 1991 Feb; 33(2):161-73. PubMed ID: 1826793
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():174-80. PubMed ID: 7914720
[TBL] [Abstract][Full Text] [Related]
10. CD45 tyrosine phosphatase controls common gamma-chain cytokine-mediated STAT and extracellular signal-related kinase phosphorylation in activated human lymphoblasts: inhibition of proliferation without induction of apoptosis.
Blank N; Kriegel M; Hieronymus T; Geiler T; Winkler S; Kalden JR; Lorenz HM
J Immunol; 2001 May; 166(10):6034-40. PubMed ID: 11342620
[TBL] [Abstract][Full Text] [Related]
11. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal.
Chaigne-Delalande B; Guidicelli G; Couzi L; Merville P; Mahfouf W; Bouchet S; Molimard M; Pinson B; Moreau JF; Legembre P
J Immunol; 2008 Dec; 181(11):7630-8. PubMed ID: 19017951
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.
Algeciras-Schimnich A; Griffith TS; Lynch DH; Paya CV
J Immunol; 1999 May; 162(9):5205-11. PubMed ID: 10227994
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion.
Gu JJ; Gathy K; Santiago L; Chen E; Huang M; Graves LM; Mitchell BS
Blood; 2003 Jun; 101(12):4958-65. PubMed ID: 12609835
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of mycophenolate mofetil.
Ransom JT
Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
[TBL] [Abstract][Full Text] [Related]
15. Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice.
Jonsson CA; Carlsten H
Clin Exp Immunol; 2001 Jun; 124(3):486-91. PubMed ID: 11472413
[TBL] [Abstract][Full Text] [Related]
16. IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide.
Griesmacher A; Weigel G; Seebacher G; Müller MM
Clin Chem; 1997 Dec; 43(12):2312-7. PubMed ID: 9439448
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil and its mechanisms of action.
Allison AC; Eugui EM
Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
[TBL] [Abstract][Full Text] [Related]
18. IMP dehydrogenase inhibitors as immunomodulators.
Mitchell BS; Dayton JS; Turka LA; Thompson CB
Ann N Y Acad Sci; 1993 Jun; 685():217-24. PubMed ID: 8103312
[TBL] [Abstract][Full Text] [Related]
19. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
20. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis.
Fournel S; Genestier L; Robinet E; Flacher M; Revillard JP
J Immunol; 1996 Nov; 157(10):4309-15. PubMed ID: 8906804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
